A complex and long-lasting dispute on the legality of granting a patent for an antidiabetic medication has completed in favor of «A.Zalesov & Partners» client
On October 02, 2023, the Presidium of the Russian IP Court adopted a very important resolution that changes the long-standing, however, erroneous approach of Rospatent to the rules for filing divisional applications.
16.10.2023
Aleksey Zalesov Irina Ozolina Maria Makhlina Darya Kushnarenko Litigation Life Science